Status:

RECRUITING

Development of Computational Models to Predict the Short-, Medium- and Long-term Cartilage Degeneration and Pain for Patients With Early-stage Osteoarthritis or Anterior Cruciate Ligament Injury

Lead Sponsor:

Aalborg University

Collaborating Sponsors:

Lund University

University of Eastern Finland

Conditions:

Osteoarthritis, Knee

Anterior Cruciate Ligament Injuries

Eligibility:

All Genders

18-70 years

Brief Summary

Knee osteoarthritis is a complex condition, and selecting effective non-drug treatments like orthoses or exercise is often difficult and imprecise. This study will follow individuals with early-stage ...

Eligibility Criteria

Inclusion

  • .3.1 ACL reconstruction group (n= 25) Inclusion criteria
  • Adults under 70 years
  • ACL injury within the last year and planned for ACL reconstruction at inclusion
  • Informed consent form signed Exclusion criteria (at inclusion)
  • Previous knee surgery before current knee trauma.
  • Severe ischemic or neurological sequelae.
  • BMI above 32.
  • Clinically significant joint disease (inflammatory or degenerative) to other joints than the ACL injured knee (according to the clinician).
  • Unsuitable for MRI (e.g. pacemaker or claustrophobia)
  • Participants not able to fit the MRI knee coil (Thigh circumference larger than 73.5 cm measured 10 cm above the kneecap and a maximum calf circumferences of 61.5 cm).
  • Drug addiction defined as the use of cannabis, opioids or other drugs as reported by the participant
  • ACL no reconstruction group (n= 25) Inclusion criteria
  • Adults under 70 years
  • ACL injury within the last year and with no plans for ACL reconstruction at inclusion
  • Informed consent form signed Exclusion criteria (at inclusion)
  • Previous knee surgery before current knee trauma.
  • Severe ischemic or neurological sequelae.
  • BMI above 32.
  • Clinically significant joint disease (inflammatory or degenerative) to other joints than the ACL injured knee (according to the clinician).
  • Unsuitable for MRI (e.g. pacemaker or claustrophobia)
  • Participants not able to fit the MRI knee coil (Thigh circumference larger than 73.5 cm measured 10 cm above the kneecap and a maximum calf circumferences of 61.5 cm).
  • Drug addiction defined as the use of cannabis, opioids or other drugs as reported by the participant
  • Early to moderate knee OA stage (n= 25) Inclusion criteria
  • Adults under 70 years
  • Diagnosis of knee OA (Kellgren Lawrence (KL) grade 1, 2 and 3 (Kohn et al., 2016). If there is no X-ray that is a maximum of 1 year old, a new one is taken.
  • Stress-related pain in the knee and knee stiffness
  • Informed consent form signed Exclusion criteria (at inclusion)
  • Previous knee surgery
  • Clinically significant joint disease (inflammatory or degenerative) of other joints than the knee at inclusion.
  • Severe ischemic or neurological sequelae in the lower extremities.
  • Clinically significant joint disease (inflammatory or degenerative) to other joints than the knees (according to the clinician).
  • BMI above 32.
  • Unsuitable for MRI (e.g., pacemaker or claustrophobia)
  • Participants not able to fit the MRI knee coil (Thigh circumference larger than 73.5 cm measured 10 cm above the kneecap and a maximum calf circumferences of 61.5 cm).
  • Drug addiction defined as the use of cannabis, opioids or other drugs as reported by the participant
  • Control groups (3 groups of 10 control participants matched for each of the patient groups, n=30) Inclusion criteria
  • Adults under 70 years
  • Informed consent form signed
  • No radiological changes on a knee x-ray (Arendt-Nielsen et al., 2015). Exclusion criteria (at inclusion)
  • Previous knee surgery
  • Self-reported Knee problems (pain, stiffness)
  • Clinically significant joint disease (inflammatory or degenerative) at inclusion.
  • Severe ischemic or neurological sequelae in the lower extremities.
  • BMI above 32.
  • Unsuitable for MRI (e.g., pacemaker or claustrophobia)
  • Participants not able to fit the MRI knee coil (Thigh circumference larger than 34.3-73.5 cm measured 10 cm above the kneecap and a maximum calf circumferences of 61.5 cm).
  • Drug addiction defined as the use of cannabis, opioids, or other drugs as reported by the participant

Exclusion

    Key Trial Info

    Start Date :

    September 26 2024

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    September 26 2036

    Estimated Enrollment :

    105 Patients enrolled

    Trial Details

    Trial ID

    NCT07134244

    Start Date

    September 26 2024

    End Date

    September 26 2036

    Last Update

    August 21 2025

    Active Locations (2)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (2 locations)

    1

    Aalborg University Hospital

    Aalborg, North Denmark, Denmark, 9000

    2

    Aalborg University

    Aalborg, Northen Denmark, Denmark, 9220